Angela H Holian1, Brian G Weinshenker2

  • 1Department of Neurology, UVA Specialty Pharmacy, University of Virginia, 1221 Lee Street, 4th Floor PCC, Charlottesville, VA, 22908, USA. arh6j@uvahealth.org.

概括

新的单克隆抗体 (mAbs) 为AQP4-IgG血清阳性患者提供有效的NMOSD治疗,显著降低攻击频率. 本综述详细介绍了它们的疗效,安全性和与旧疗法相比的使用情况.